AGP Executive Report
Last update: 6 hours agoFDA Approval: The FDA cleared Revolution Medicines’ once-daily Rasonque pill for advanced metastatic pancreatic cancer, a move aimed at speeding options for a historically hard-to-treat disease. Medical Supply Risk: Medtronic/Covidien recalled 135,875 V-Loc 90 absorbable sutures after reports of torn sterile packaging, with clinicians told to monitor patients already treated. Biomanufacturing Expansion: Argentina’s Biosidus brought a new bioreactor plant online to boost biologics capacity for agalsidase beta and strengthen supply continuity. Industrial AI & OEE: A manufacturing-focused piece argues that scaling quality and OEE needs better data governance and connected workflows, so AI recommendations can be trusted on the plant floor. Trade & Tariffs: Multiple reports highlight how tariff resets and Canada/U.S. retaliation are raising costs and exposing supply-chain blind spots for manufacturers beyond their direct suppliers. Aerospace Co-Design: India’s HAL and Safran’s JV signed to co-develop the Aravalli turboshaft engine for next-gen helicopters, shifting from licensed production to joint design. Maritime Decarbonization: CSL and Adbri started operations of MV Yampu, a battery-powered self-unloading bulk carrier to cut diesel use while feeding local cement manufacturing. Safety & Compliance: China’s NEV makers face recalls tied to emergency door-release issues, underscoring tightening safety scrutiny as global standards evolve. Food Manufacturing Recalls: Donutful mini donuts were recalled over undeclared milk allergen risk, and separate donut recalls continued to ripple across online retail.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.